Top

Supportive Care in Cancer

Published in:

01-04-1998 | REVIEW ARTICLE

Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity

Authors: P. J. Hesketh, Richard J. Gralla, Andreas du Bois, Maurizio Tonato

Published in: Supportive Care in Cancer | Issue 3/1998

Title: Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity
Authors: P. J. Hesketh
Richard J. Gralla
Andreas du Bois
Maurizio Tonato
Publication date: 01-04-1998
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 3/1998
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s005200050157

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/1998

Corticosteroids, dopamine antagonists and other drugs

Psycho-oncology and supportive care: an interview with Darius Razavi

Consensus regarding multiple day and rescue antiemetic therapy

Palliative care of cancer patients: audit of current hospital procedures

Oncology Home Care Service

Neuropharmacology of emesis and its relevance to anti-emetic therapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer